Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Embecta Corp.

Embecta Corp. (EMBCV) Stock Overview

Explore Embecta Corp.’s financial performance, market position, analyst ratings, and future outlook.

EMBCV●NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$33.33
$3.43(9.33%)
U.S. Market is Open · 13:56

Embecta Corp. (EMBCV)

Meyka AI Score

Z

Key Financials

Market Cap1.9B
P/E Ratio22.37
EPS (TTM)N/A
ROE-0.19%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

EMBCV Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Embecta Corp. (NASDAQ: EMBCV) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Embecta Corp.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of EMBCV on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $N/A for the NASDAQ listing.

Key metrics behind Embecta Corp.'s NASDAQ-traded stock include a P/E ratio of 22.37 and a market capitalization of 1.9B. Combined with our AI analysis, these give both institutional and retail investors a clear view of EMBCV on the NASDAQ.

Price Performance (NASDAQ: EMBCV)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
-29.09%
3-Year Change
-29.09%
5-Year Change
-29.09%
All-Time (Max) Change
-29.09%

Contact Information

https://www.embecta.com
(201) 847-6800
1 Becton Drive, Franklin Lakes, NJ, 07054

Company Facts

20,290 Employees
IPO DateMar 21, 2022
CountryUS

Frequently Asked Questions